Sign in
4

Changes in Ownership

Ensysce Biosciences, Inc. Filed Acc 0001192482-21-000614

Options or other derivatives

  • Chief Business Officer acquired 1,386,730 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Wright Richard Chester · Chief Business Officer

Table II: Derivative

5 lines
Date Transaction Shares Owned after D/I
2021-06-30 Grant or award : show line 1 in the form Stock Option +49,975 49,975 D
2021-06-30 Grant or award : show line 2 in the form Stock Option +65,850 65,850 D
2021-06-30 Grant or award : show line 3 in the form Stock Option +263,400 263,400 D
2021-06-30 Grant or award : show line 4 in the form Stock Option +19,755 19,755 D
2021-06-30 Grant or award : show line 5 in the form Stock Option +987,750 987,750 D
Loading xslF345X03/edgar.xml…